I am a registered nurse. I believe in medicine. If you are having a heart attack, a stroke, a bad break, an infection turning septic — go to the hospital, and go fast. Emergency and acute care save lives every single day, and nothing here argues against that. But there is a second story I have watched play out at bedsides and in clinics for years: people who are not in a crisis getting layered with more and more intervention, each one aimed at a symptom, none of them asking why the body is behaving this way in the first place. Somewhere along the line, the care itself starts adding to the load. This is about knowing the difference.
The reflex to treat the number, not the person
Modern care is built to react. A number comes back off, and the reflex is to push it back into range — often with a medication. Sometimes that is exactly right and buys real time. But a lab value is a signal, not a cause. When we only silence the signal, the underlying story keeps running in the background. I have seen a patient on five medications where two of them existed only to manage the side effects of the other three. Nobody set out to do that. It happened one reasonable-in-the-moment decision at a time.
- A high number treated in isolation tells you the alarm is loud, not why it is going off.
- Every intervention has a cost — a side effect, an interaction, a follow-up, a bit of trust spent.
- Costs stack quietly. No single step looks like too much until you count them all together.
Where the harm actually shows up
Over-intervention is not a slogan, it is a measurable pattern with a name in the research literature: overdiagnosis and overtreatment. It looks like a borderline finding that triggers a scan, that finds an incidental shadow, that leads to a biopsy, that carries its own risk — all for something that may never have caused harm. It looks like polypharmacy, where the sheer number of prescriptions creates interactions no one is tracking. It looks like a person so managed by the system that they have stopped listening to their own body, because a screen and a script now speak for it. The harm is real, and it is rarely dramatic. It is slow.
Root cause is not anti-medicine. It is better sequencing.
Here is the framing I keep coming back to. The body is a system built to self-regulate. Give the cell what it needs and remove what is poisoning it, and function tends to move back toward normal on its own. That is structure and function — support the structure, and the function follows. Root-cause work asks a different first question than symptom management. Not "what can I add to push this number down" but "what is missing, and what is in the way." That is not a rejection of medicine. It is putting the cheapest, safest, most upstream move first, and holding the heavier interventions for when they are truly needed.
- Ask what the body is short on before asking what to add on top of it.
- Ask what is interfering — diet, sleep, stress, an exposure — before escalating the treatment.
- Reserve aggressive intervention for where it earns its risk: emergencies and genuine acute disease.
Deficiency and toxicity: the two questions worth asking first
Most chronic, low-grade dysfunction sits on one of two sides. Either the cell is not getting enough of what it needs to run — a deficiency — or it is carrying something that gets in the way — a toxicity, in the broad sense of an interfering load. When you start from those two questions, a lot of symptoms that looked like separate problems turn out to share a source. Fix the source and several downstream complaints ease at once, which is the opposite of the medication cascade where each fix spawns the next. This is why we measure at the cellular level rather than guess: you cannot correct a deficiency you have not confirmed, and you cannot clear a load you have not seen.
Sovereignty: you are allowed to be the one steering
The word I care about most here is sovereignty. It means you stay the decision-maker over your own body. Care should hand you understanding and options, not hand your judgment over to a chart. A good clinician is a guide, not a gatekeeper standing between you and your own biology. When you actually understand what is happening at the cellular level — what you are short on, what is weighing you down — you can make calmer, sharper choices, ask better questions, and say "let us look upstream first" without fear. That is not going it alone. That is being an informed partner in your own care instead of a passenger.
- Understanding turns you from passenger into driver.
- You can honor emergency medicine and still refuse to over-manage a body that is not in crisis.
- The goal is fewer, smarter interventions — not zero, and not endless.
How we measure before we intervene
This is exactly why cellular measurement sits at the center of what we do at theholistichub.org. Rather than treating a symptom in the dark, we look first at how your cells are actually functioning, so any step we take is aimed at a cause you can see. PRYSM iO is our clinically validated cellular assessment, and it's backed by a performance guarantee — re-scan and your score goes up, measurably, or your money back — because when you correct the right thing at the root, the body tends to respond. Measure, understand, support what is deficient, remove what is interfering, and give function room to return. That is care that respects the system instead of overriding it.
Key Takeaways
- Emergency and acute medicine save lives — this is about non-crisis care that over-intervenes and quietly adds harm.
- Treating a number in isolation silences the alarm without answering why it is ringing.
- Root-cause work is not anti-medicine — it puts the safest, most upstream move first and saves heavy intervention for when it is earned.
- Start with two questions: what is the cell short on, and what is getting in its way.
- Sovereignty means you stay the driver — understanding your own cellular data lets you choose fewer, smarter interventions.
Sources
Powered by CellWell.life- 1.Health Outcomes Associated with Polypharmacy in Community-Dwelling Older Adults: A Systematic Review (2014)
- 2.Polypharmacy among Adults Aged 65 Years and Older in the United States: 1988-2010 (2015)
- 3.A review of pharmacogenetics of adverse drug reactions in elderly people (2012)
Related